Glenmark Pharma arm acquires and launches Acetylcysteine injection in US

Share it

Glenmark Pharma Share Price | This new product will be available in the strength of 6 gm/30 mL (200 mg/mL) single-dose vials in the US market, marking an expansion of Glenmark’s injectable portfolio.

Leave a Comment

Your email address will not be published. Required fields are marked *